{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:50:21Z","timestamp":1764402621355},"reference-count":93,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"USD"},{"DOI":"10.13039\/100000001","name":"NSF","doi-asserted-by":"publisher","award":["CHE 0840507"],"award-info":[{"award-number":["CHE 0840507"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P20GM103443","AI-010085"],"award-info":[{"award-number":["P20GM103443","AI-010085"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.vaccine.2014.06.093","type":"journal-article","created":{"date-parts":[[2014,7,29]],"date-time":"2014-07-29T07:16:01Z","timestamp":1406618161000},"page":"5241-5249","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus:S. pyogenes super-infection"],"prefix":"10.1016","volume":"32","author":[{"given":"Joshua M.","family":"Klonoski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather R.","family":"Hurtig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian A.","family":"Juber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret J.","family":"Schuneman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Bickett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua M.","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Burum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Penfound","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grigoriy","family":"Sereda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Chaussee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor C.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"November (11)","key":"10.1016\/j.vaccine.2014.06.093_bib0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2014.06.093_bib0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.inf.0000255328.19808.be","article-title":"Chronic pharyngeal carriage of group A streptococci","volume":"26","author":"Tanz","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2014.06.093_bib0015","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.qco.0000216623.82950.11","article-title":"Group A streptococcal infections of the skin: molecular advances but limited therapeutic progress","volume":"19","author":"Currie","year":"2006","journal-title":"Curr Opin Infect Dis"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2014.06.093_bib0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.spid.2006.07.001","article-title":"Group A streptococcus","volume":"17","author":"Martin","year":"2006","journal-title":"Semin Pediatr Infect Dis"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2014.06.093_bib0025","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/521264","article-title":"The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000\u20132004","volume":"45","author":"O\u2019Loughlin","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2014.06.093_bib0030","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.micpath.2010.06.012","article-title":"Lower respiratory tract infection in cynomolgus macaques (Macaca fascicularis) infected with group A Streptococcus","volume":"49","author":"Olsen","year":"2010","journal-title":"Microb Pathog"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2014.06.093_bib0035","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archinte.163.4.467","article-title":"Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario, Canada","volume":"163","author":"Muller","year":"2003","journal-title":"Arch Intern Med"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2014.06.093_bib0040","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrmicro3231","article-title":"The co-pathogenesis of influenza viruses with bacteria in the lung","volume":"12","author":"McCullers","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2014.06.093_bib0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/hv.8.1.18214","article-title":"Correlates of vaccine protection from influenza and its complications","volume":"8","author":"McCullers","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2014.06.093_bib0050","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2014.06.093_bib0055","doi-asserted-by":"crossref","first-page":"e20661","DOI":"10.1371\/journal.pone.0020661","article-title":"Excess mortality associated with influenza epidemics in portugal, 1980 to 2004","volume":"6","author":"Nunes","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.06.093_bib0060","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/1471-2334-11-350","article-title":"Excess mortality related to seasonal influenza and extreme temperatures in Denmark, 1994\u20132010","volume":"11","author":"Nielsen","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2014.06.093_bib0065","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1017\/S0950268810000671","article-title":"Estimating influenza-related excess mortality and reproduction numbers for seasonal influenza in Norway, 1975\u20132004","volume":"138","author":"Gran","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"12","key":"10.1016\/j.vaccine.2014.06.093_bib0070","doi-asserted-by":"crossref","first-page":"e8096","DOI":"10.1371\/journal.pone.0008096","article-title":"Influenza excess mortality from 1950\u20132000 in tropical Singapore","volume":"4","author":"Lee","year":"2009","journal-title":"PLoS ONE"},{"issue":"July (21\u201322)","key":"10.1016\/j.vaccine.2014.06.093_bib0075","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.vaccine.2003.12.024","article-title":"Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection","volume":"22","author":"Okamoto","year":"2004","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2014.06.093_bib0080","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3201\/eid1402.070888","article-title":"Severe Streptococcus pyogenes infections, United Kingdom, 2003\u20132004","volume":"14","author":"Lamagni","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2014.06.093_bib0085","doi-asserted-by":"crossref","first-page":"pii=19780","DOI":"10.2807\/ese.16.05.19780-en","article-title":"Group A streptococcal infections during the seasonal influenza outbreak 2010\/11 in South East England","volume":"16","author":"Scaber","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2014.06.093_bib0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-0-387-73960-1_5","article-title":"Current status of group A streptococcal vaccine development","volume":"609","author":"Dale","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2014.06.093_bib0095","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1128\/JCM.41.10.4808-4811.2003","article-title":"National Department of Defense surveillance data for antibiotic resistance and emm gene types of clinical group A streptococcal isolates from eight basic training military sites","volume":"41","author":"Barrozo","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"October (10 Suppl.)","key":"10.1016\/j.vaccine.2014.06.093_bib0100","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/INF.0b013e3181684d41","article-title":"Preparing for the next influenza pandemic","volume":"27","author":"McCullers","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"June (27\u201328)","key":"10.1016\/j.vaccine.2014.06.093_bib0105","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1016\/j.vaccine.2008.04.041","article-title":"Influenza immunization and subsequent diagnoses of group A streptococcus-illnesses among U.S. Amy trainees, 2002\u20132006","volume":"26","author":"Lee","year":"2008","journal-title":"Vaccine"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2014.06.093_bib0110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3201\/eid0503.990308","article-title":"Respiratory diseases among U.S. military personnel: countering emerging threats","volume":"5","author":"Gray","year":"1999","journal-title":"Emerg Infect Dis"},{"issue":"21","key":"10.1016\/j.vaccine.2014.06.093_bib0115","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2011.03.031","article-title":"Inactivated and live, attenuated influenza vaccines protect mice against influenza:Streptococcus pyogenes super-infections","volume":"29","author":"Chaussee","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.093_bib0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/epirev\/mxj003","article-title":"Immunization to protect the US Armed Forces: heritage, current practice, and prospects","volume":"28","author":"Grabenstein","year":"2006","journal-title":"Epidemiol Rev"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2014.06.093_bib0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.inf.0000217370.83948.51","article-title":"Effectiveness of inactivated influenza vaccine for prevention of otitis media in children","volume":"25","author":"Ozgur","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2014.06.093_bib0130","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archpedi.1995.02170230067009","article-title":"Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care","volume":"149","author":"Clements","year":"1995","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2014.06.093_bib0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0264-410X(98)00150-9","article-title":"Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments","volume":"17","author":"Dale","year":"1999","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2014.06.093_bib0140","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.72.5.2507-2512.2004","article-title":"Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections","volume":"72","author":"Hall","year":"2004","journal-title":"Infect Immun"},{"issue":"August (6)","key":"10.1016\/j.vaccine.2014.06.093_bib0145","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.292.6.709","article-title":"Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial","volume":"292","author":"Kotloff","year":"2004","journal-title":"JAMA"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2014.06.093_bib0150","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"December (24)","key":"10.1016\/j.vaccine.2014.06.093_bib0155","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1039\/b411916a","article-title":"TAT conjugated, FITC doped silica nanoparticles for bioimaging applications","volume":"21","author":"Santra","year":"2004","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.vaccine.2014.06.093_bib0160","series-title":"Fmoc solid phase peptide synthesis: a practical approach","year":"2000"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2014.06.093_bib0165","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1021\/jf030490p","article-title":"Applications of the ninhydrin reaction for analysis of amino acids, peptides, and proteins to agricultural and biomedical sciences","volume":"52","author":"Friedman","year":"2004","journal-title":"J Agric Food Chem"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2014.06.093_bib0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/bc060255n","article-title":"Fluorescent nanoparticles for multiplexed bacteria monitoring","volume":"18","author":"Wang","year":"2007","journal-title":"Bioconjug Chem"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2014.06.093_bib0175","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.vaccine.2008.12.023","article-title":"A multi-valent vaccine approach that elicits broad immunity within an influenza subtype","volume":"27","author":"Huber","year":"2009","journal-title":"Vaccine"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2014.06.093_bib0180","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0264-410X(88)80027-6","article-title":"Protective and autoimmune epitopes of streptococcal M proteins","volume":"6","author":"Beachey","year":"1988","journal-title":"Vaccine"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2014.06.093_bib0185","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/JVI.02621-09","article-title":"Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications","volume":"84","author":"Huber","year":"2010","journal-title":"J Virol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2014.06.093_bib0190","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2105\/AJPH.1.9.643","article-title":"Section of Municipal Health Officers: some preliminary note on the use of streptococcus vaccine as a means of prophylaxis against scarlet fever","volume":"1","author":"Biwer","year":"1911","journal-title":"J Am Public Health Assoc"},{"issue":"5","key":"10.1016\/j.vaccine.2014.06.093_bib0195","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/infdis\/5.5.608","article-title":"The injections of heterologous streptococci, killed by galactose, in erysipelas and in scarlet fever","volume":"5","author":"Weaver","year":"1908","journal-title":"J Infect Dis"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2014.06.093_bib0200","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1084\/jem.69.3.425","article-title":"Antigenic properties of the type-specific substance derived from Group A hemolytic streptococci","volume":"69","author":"Hirst","year":"1939","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.06.093_bib0205","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.89.3.307","article-title":"Current knowledge of type-specific M antigens of group A streptococci","volume":"89","author":"Lancefield","year":"1962","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2014.06.093_bib0210","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrmicro2648","article-title":"Molecular insight into invasive group A streptococcal disease","volume":"9","author":"Cole","year":"2011","journal-title":"Nat Rev Microbiol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2014.06.093_bib0215","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(09)70178-1","article-title":"Global emm type distribution of group A streptococci: systematic review and implications for vaccine development","volume":"9","author":"Steer","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2014.06.093_bib0220","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1128\/IAI.64.5.1495-1501.1996","article-title":"Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci","volume":"64","author":"Dale","year":"1996","journal-title":"Infect Immun"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2014.06.093_bib0225","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.4049\/jimmunol.128.4.1897","article-title":"Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis","volume":"128","author":"Jacks-Weis","year":"1982","journal-title":"J Immunol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2014.06.093_bib0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.96.1.71","article-title":"Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus","volume":"96","author":"Lancefield","year":"1952","journal-title":"J Exp Med"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2014.06.093_bib0235","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.110.2.271","article-title":"Persistence of type-specific antibodies in man following infection with group A streptococci","volume":"110","author":"Lancefield","year":"1959","journal-title":"J Exp Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2014.06.093_bib0240","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.47.1.91","article-title":"The antigenic complex of streptococcus haemolyticus: I. Demonstration of a type-specific substance in extracts of Streptococcus hemolyticus","volume":"47","author":"Lancefield","year":"1928","journal-title":"J Exp Med"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2014.06.093_bib0245","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1084\/jem.167.3.1114","article-title":"The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci","volume":"167","author":"Jones","year":"1988","journal-title":"J Exp Med"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2014.06.093_bib0250","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/657144","article-title":"Efficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic","volume":"202","author":"Chien","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.093_bib0255","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jama.1919.26110010003009","article-title":"Influenza as seen at the Puget Sound Navy Yard","volume":"72","author":"Ely","year":"1919","journal-title":"JAMA"},{"issue":"November (45)","key":"10.1016\/j.vaccine.2014.06.093_bib0260","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1073\/pnas.1014515107","article-title":"FcgammaRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo","volume":"107","author":"Nimmerjahn","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2014.06.093_bib0265","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.vaccine.2008.02.063","article-title":"Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection","volume":"26","author":"Bungener","year":"2008","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2014.06.093_bib0270","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/intimm\/7.9.1519","article-title":"Interleukin 12 alters the isotype-restricted antibody response of mice to hen eggwhite lysozyme","volume":"7","author":"Buchanan","year":"1995","journal-title":"Int Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2014.06.093_bib0275","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0161-5890(90)90071-7","article-title":"Protein H \u2013 a novel IgG binding bacterial protein","volume":"27","author":"Akesson","year":"1990","journal-title":"Mol Immunol"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2014.06.093_bib0280","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.4049\/jimmunol.163.6.3396","article-title":"Fc-mediated nonspecific binding between fibronectin-binding protein I of Streptococcus pyogenes and human immunoglobulins","volume":"163","author":"Medina","year":"1999","journal-title":"J Immunol"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2014.06.093_bib0285","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1093\/emboj\/20.12.3046","article-title":"a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG","volume":"20","author":"Collin","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2014.06.093_bib0290","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.molimm.2011.08.002","article-title":"The deficient cleavage of M protein-bound IgG by IdeS: insight into the escape of Streptococcus pyogenes from antibody-mediated immunity","volume":"49","author":"Su","year":"2011","journal-title":"Mol Immunol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2014.06.093_bib0295","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/emboj\/21.7.1607","article-title":"IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G","volume":"21","author":"von Pawel-Rammingen","year":"2002","journal-title":"EMBO J"},{"issue":"December (13)","key":"10.1016\/j.vaccine.2014.06.093_bib0300","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1084\/jem.20120325","article-title":"Antibody orientation at bacterial surfaces is related to invasive infection","volume":"209","author":"Nordenfelt","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.06.093_bib0305","first-page":"3","article-title":"Interactions of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria","volume":"19","author":"Allison","year":"1974","journal-title":"Transplant Rev"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2014.06.093_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/147.1.1","article-title":"Factors influencing antibody responses to streptococcal M proteins in humans","volume":"147","author":"Flores","year":"1983","journal-title":"J Infect Dis"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2014.06.093_bib0315","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1073\/pnas.85.5.1657","article-title":"Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H","volume":"85","author":"Horstmann","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"30","key":"10.1016\/j.vaccine.2014.06.093_bib0320","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.vaccine.2014.05.017","article-title":"Working towards a Group A Streptococcal vaccine: report of a collaborative Trans-Tasman workshop","volume":"32","author":"Moreland","year":"2014","journal-title":"Vaccine"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2014.06.093_bib0325","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/infdis\/jis935","article-title":"Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase","volume":"207","author":"Couch","year":"2013","journal-title":"J Infect Dis"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2014.06.093_bib0330","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2014.06.093_bib0335","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1016\/j.vaccine.2006.03.091","article-title":"Neisseria meningitidis group B correlates of protection and assay standardization \u2013 international meeting report Emory University, Atlanta, Georgia, United States, 16\u201317 March 2005","volume":"24","author":"Borrow","year":"2006","journal-title":"Vaccine"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2014.06.093_bib0340","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1128\/CVI.00194-09","article-title":"Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays","volume":"16","author":"Verma","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2014.06.093_bib0345","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1073\/pnas.76.3.1400","article-title":"Fc-receptor variants of a mouse macrophage cell line","volume":"76","author":"Unkeless","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"June (6 Pt 1)","key":"10.1016\/j.vaccine.2014.06.093_bib0350","first-page":"L958","article-title":"Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria","volume":"274","author":"Hartshorn","year":"1998","journal-title":"Am J Physiol"},{"issue":"May (2)","key":"10.1016\/j.vaccine.2014.06.093_bib0355","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/IAI.32.2.625-631.1981","article-title":"Characterization of lipoteichoic acid binding to polymorphonuclear leukocytes of human blood","volume":"32","author":"Courtney","year":"1981","journal-title":"Infect Immun"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2014.06.093_bib0360","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.4049\/jimmunol.161.9.4894","article-title":"Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor","volume":"161","author":"Johnsson","year":"1998","journal-title":"J Immunol"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2014.06.093_bib0365","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/CMR.00058-05","article-title":"Insights into the interaction between influenza virus and pneumococcus","volume":"19","author":"McCullers","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2014.06.093_bib0370","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm1765","article-title":"Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection","volume":"14","author":"Sun","year":"2008","journal-title":"Nat Med"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2014.06.093_bib0375","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.4049\/jimmunol.1301152","article-title":"Immune dysfunction and bacterial coinfections following influenza","volume":"191","author":"Metzger","year":"2013","journal-title":"J Immunol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2014.06.093_bib0380","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/infdis\/jiq113","article-title":"Influenza virus primes mice for pneumonia from Staphylococcus aureus","volume":"203","author":"Iverson","year":"2011","journal-title":"J Infect Dis"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2014.06.093_bib0385","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.4049\/jimmunol.1301237","article-title":"Influenza A exacerbates Staphylococcus aureus pneumonia by attenuating IL-1beta production in mice","volume":"191","author":"Robinson","year":"2013","journal-title":"J Immunol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2014.06.093_bib0390","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/infdis\/jit527","article-title":"Influenza A virus exacerbates Staphylococcus aureus pneumonia in mice by attenuating antimicrobial peptide production","volume":"209","author":"Robinson","year":"2014","journal-title":"J Infect Dis"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2014.06.093_bib0395","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/368163","article-title":"Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae","volume":"187","author":"McCullers","year":"2003","journal-title":"J Infect Dis"},{"issue":"December (13)","key":"10.1016\/j.vaccine.2014.06.093_bib0400","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1084\/jem.20080201","article-title":"Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand","volume":"205","author":"Herold","year":"2008","journal-title":"J Exp Med"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2014.06.093_bib0405","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/infdis\/119.6.541","article-title":"Interaction of influenza virus with leukocytes and its effect on phagocytosis","volume":"119","author":"Sawyer","year":"1969","journal-title":"J Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2014.06.093_bib0410","first-page":"269","article-title":"Effect of influenza viral infection on the ingestion and killing of bacteria by alveolar macrophages","volume":"115","author":"Warshauer","year":"1977","journal-title":"Am Rev Respir Dis"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2014.06.093_bib0415","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1128\/IAI.36.3.1154-1159.1982","article-title":"Role of macrophage activation and interferon in the resistance of alveolar macrophages from infected mice to influenza virus","volume":"36","author":"Rodgers","year":"1982","journal-title":"Infect Immun"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2014.06.093_bib0420","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/excr.1997.3602","article-title":"Characterization of influenza virus-induced death of J774.1 macrophages","volume":"234","author":"Lowy","year":"1997","journal-title":"Exp Cell Res"},{"issue":"9","key":"10.1016\/j.vaccine.2014.06.093_bib0425","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1365-3083.1977.tb00410.x","article-title":"Depression of human neutrophil motility by influenza virus in vitro","volume":"6","author":"Ruutu","year":"1977","journal-title":"Scand J Immunol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2014.06.093_bib0430","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood.V93.7.2395","article-title":"A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria","volume":"93","author":"Colamussi","year":"1999","journal-title":"Blood"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2014.06.093_bib0435","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/QCO.0b013e3283458f7e","article-title":"New understandings in Streptococcus pyogenes","volume":"24","author":"Lynskey","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2014.06.093_bib0440","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-0484","article-title":"Burden and economic cost of group A streptococcal pharyngitis","volume":"121","author":"Pfoh","year":"2008","journal-title":"Pediatrics"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2014.06.093_bib0445","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1128\/IAI.72.10.6068-6075.2004","article-title":"The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection","volume":"72","author":"Okamoto","year":"2004","journal-title":"Infect Immun"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2014.06.093_bib0450","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/JVI.77.7.4104-4112.2003","article-title":"Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice","volume":"77","author":"Okamoto","year":"2003","journal-title":"J Virol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2014.06.093_bib0455","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1128\/IAI.72.5.2956-2963.2004","article-title":"Role of macrophages in host resistance to group A streptococci","volume":"72","author":"Goldmann","year":"2004","journal-title":"Infect Immun"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2014.06.093_bib0460","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2014.06.093_bib0465","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s002770050396","article-title":"The IgG Fc receptor family","volume":"76","author":"Gessner","year":"1998","journal-title":"Ann Hematol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14009797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14009797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T15:18:57Z","timestamp":1689434337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14009797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":93,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0264410X14009797"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.093","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus:S. pyogenes super-infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}